Machine learning reveals prominent spontaneous behavioral changes and treatment efficacy in humanized and transgenic Alzheimer's disease models
Stephanie R. Miller(Gladstone Institutes), Jorge J. Palop(Gladstone Institutes), Takashi Saito(Nagoya City University), Katie K. Ly(Gladstone Institutes), Pavol Bauer(Leibniz Institute for Neurobiology), Takaomi C. Saido(RIKEN Center for Brain Science), Kevin Shen(Gladstone Institutes), Reuben Thomas(Gladstone Institutes), Andrew S. Mendiola(Gladstone Institutes), Patrick Honma(Gladstone Institutes), Zhaoqi Yan(Gladstone Institutes), Catherine W. Cai(Gladstone Institutes), Kevin Luxem(Leibniz Institute for Neurobiology), Stefan Remy(German Center for Neurodegenerative Diseases), Yuechen Qiu(Gladstone Institutes), Alexander R. Pico(Gladstone Institutes), Erik D. Roberson(University of Alabama at Birmingham), Mary Bullock(University of Alabama at Birmingham), N. Kaliss(Gladstone Institutes), Kelli Lauderdale(Gladstone Institutes), K Dakota Mallen(Gladstone Institutes), Pranav Nambiar(Gladstone Institutes), Shreya C. Bangera(Gladstone Institutes), Katerina Akassoglou(Gladstone Institutes)
Cited by 19
Related Papers
Network abnormalities and interneuron dysfunction in Alzheimer disease
|Nature reviews. Neuroscience|2016|1k
The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques
|Cell Reports|2019|978
<scp>APP</scp> mouse models for Alzheimer's disease preclinical studies
|The EMBO Journal|2017|780